Alvotech Corp - ALVO Net Assets per Single Share

Graphic logo of Alvotech (ALVO)

Alvotech focuses on producing low-cost biosimilars of expensive biological drugs using a fully integrated proprietary production cycle. This price chart reflects a value of -0.54. The business relies on robotic cell cultivation systems that eliminate human error. Stability is guaranteed by a lack of dependence on Eastern supplies and the presence of capacities in Europe and Iceland.

Alvotech S.A. (ALVO): Share Book Value from 04/28/2023 to 10/26/2026

alvotech.com - analytical breakdowns and key metrics (ALVO)

- price and consensus price forecast:
Stock Quotes Alvotech Corp|ALVO - Price Target Chart
- market capitalization data:
Market Value Alvotech SA|ALVO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Alvotech|ALVO - Net Asset Value|Market Capitalization to Book Value Ratio alvotech.com|ALVO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Alvotech|ALVO - Long-Term Debt to Capital|Short-Term Debt to Equity Alvotech SA|ALVO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Alvotech SA
Fundamental company valuation:Alvotech Corp - ALVO
Manufactured products of Alvotech SA

Alvotech maintains a strong position in the biosimilars sector due to transparent regulatory processes and management expertise. This indicator reflects the net asset value, calculated as the difference between equity and liabilities per share. Investors use this basis to determine the intrinsic value of the business. The price action on the equity per common share chart confirms financial stability. The growth of this metric minimizes the risks of stock overvaluation.

Competitors of Alvotech (ALVO)

HLN - Accounting Value per Share|KVUE: Net Assets per Single Share|Net Assets per Single Share VRNA|MENS (jyongbio.com) - Net Asset Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Liquidia Inc. (LQDA)|Book Value per Share GLPG (Galapagos NV)|anipharmaceuticals.com - Book Value per Share|Net Assets per Single Share MannKind (MNKD)|AMPH: Accounting Value of a Share|PCRX (Pacira) - Net Assets per Single Share|ARS Corp (SPRY) - Accounting Value per Share|TBPH (Theravance Biopharma) - Book Value per Share|Book Value per Share aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|Book Value per Share QNTM (Quantum BioPharma)|FibroGen Inc - Book Value per Share|TELO - Net Assets per Single Share|Rani Therapeutics (RANI) - Net Assets per Single Share|synergychc.com (SNYR) - Accounting Value per Share|RLYB (Rallybio) - Net Assets per Single Share|Net Assets per Single Share LEXX (Lexaria Bioscience Corp)|Net Asset Value per Share Pulmatrix Inc (PULM)|Accounting Value per Share Pheton Holdings Ltd|Book Price of a Share aptorumgroup.com (APM)|LYRA: Book Value per Share|Net Asset Value per Share Impact BioMedical, Inc. IBO|TNFA: Book Value per Share|YCBD - Accounting Value per Share|Book Value per Share PainReform Limited PRFX|Altamira Therapeutics Ltd. (CYTO) - Accounting Value of a Share|LIPO (Lipella Pharmaceuticals) - Book Value per Share|Book Value per Share OPTN|Net Assets per Single Share Pieris Pharmaceuticals, Inc. (PIRS)|Net Assets per Single Share Procaps Group PROC|Accounting Value per Share Petros PTPI|Qilian International Corp - Net Assets per Single Share|SLRN (Acelyrin, Inc.) - Net Assets per Single Share|TFFP: Net Asset Value per Share